Improvement of Accommodation With Anti-Oxidant Supplementation in Visual Display Terminal Users

This study has been completed.
Sponsor:
Information provided by:
Ryogoku Eye Clinic
ClinicalTrials.gov Identifier:
NCT00877201
First received: April 6, 2009
Last updated: April 7, 2009
Last verified: April 2009
  Purpose

The purpose of this study is to determine the antioxidant supplementation effect on accommodation among visual display terminal (VDT) users.


Condition Intervention
Ocular Accommodation
Drug: CDR2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Supportive Care

Resource links provided by NLM:


Further study details as provided by Ryogoku Eye Clinic:

Primary Outcome Measures:
  • accommodation changes

Study Start Date: March 2007
  Eligibility

Ages Eligible for Study:   40 Years to 49 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • best corrected visual acuity is over 20/20

Exclusion Criteria:

  • receiving any medication or supplement that would alter the accommodation status within a week from the commencement of this study
  • using multifocal spectacles or contact lenses
  • pregnant or lactating mothers
  • subjects with a history of drug allergy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00877201

Locations
Japan
Iidabashi Eye Clinic
Tokyo, Japan, 102-0072
Sponsors and Collaborators
Ryogoku Eye Clinic
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00877201     History of Changes
Other Study ID Numbers: Ryogoku6886
Study First Received: April 6, 2009
Last Updated: April 7, 2009
Health Authority: Japan: Institutional Review Board

Keywords provided by Ryogoku Eye Clinic:
Accommodation
visual display terminal (VDT)
antioxidant

Additional relevant MeSH terms:
Antioxidants
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protective Agents
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on April 16, 2014